Telomir Pharmaceuticals, Inc. Other Current Liabilities
Telomir Pharmaceuticals, Inc. (TELO) had Other Current Liabilities of $344.83 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-05-14
- 2026-03-31: Other Liabilities, Current $344.83K.
- 2025-12-31: Other Liabilities, Current $318.23K.
- 2025-09-30: Other Liabilities, Current $93.43K.
- 2025-06-30: Other Liabilities, Current $93.43K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-03-31 | $344.83K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $318.23K 10-Q · filed 2026-05-14 |
| 2025-09-30 | $93.43K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $93.43K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $93.43K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $93.43K 10-K · filed 2026-03-17 |
| 2023-12-31 | $527.38K 10-K · filed 2025-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |